ISLAMABAD: The Federal Investigation Agency (FIA) has decided to approach a magistrate to get arrest warrants against the Drug Regulatory Authority of Pakistan (Drap) chief executive officer (CEO) for reluctance to appear before the investigation agency.

The case is about an application lodged against the Drap chief by Dr Muhammad Aleem Akhtar, a Drap official, claiming the authority’s CEO runs a pharma company, which is a conflict of interest.

The official filed applications with the National Accountability Bureau (NAB) and the FIA and then approached the court, alleging that the investigation agencies were not taking action over his application.

A division bench of the Balochistan High Court, comprising Justice Muhammad Kamran Khan Mulakhail and Justice Shoukat Ali Rakhshani, directed the FIA to submit a report by October 30. According to a court document available with Dawn, the assistant attorney general submitted a report on behalf of the FIA and stated that in pursuance of the complaint received by the FIA, notices were issued to the accused but he did not respond. In light of this refusal to join the inquiry, the FIA has decided to proceed against him by filing a complaint before the magistrate for the issuance of warrants against the Drap CEO.

Agency to approach magistrate for arrest warrants; Balochistan High Court seeks report by Oct 30

Subsequently, the court sought a report by October 30. An official of the Drap, wishing not to be named, said that the official approached the FIA and NAB, without seeking approval of the Drap and the health ministry, which was a violation of the code of conduct. He said that because of the frivolous applications, it was decided to terminate the service of the officer who levelled allegations against the CEO.

However, Dr Muhammad Aleem also challenged the termination orders in the apex court, claiming that the authority took action against him for whistleblowing.

It is worth mentioning that Drap was established under the Drap Act 2012. It is responsible for providing effective coordination and enforcement of the Drugs Act, 1976 (XXXI of 1976) and to bring harmony in inter-provincial trade and commerce of therapeutic goods.

Therapeutic goods regulated by Drap include pharmaceutical and biological drugs for human or veterinary use, medical devices and medical cosmetics, health, and OTC (non-drugs) also known as alternative medicines, such as Ayurvedic and homoeopathy.

Drap also ensures that therapeutic goods, approved and available in the market, meet prescribed standards of quality, safety and efficacy.

The regulatory functions performed by Drap include registration and marketing authorisation, vigilance, market surveillance and control, licencing establishments, regulatory inspection, laboratory testing, clinical trial oversight, and pharmacovigilance.

Published in Dawn, October 7th, 2024

Opinion

Editorial

Military option
Updated 21 Nov, 2024

Military option

While restoring peace is essential, addressing Balochistan’s socioeconomic deprivation is equally important.
HIV/AIDS disaster
21 Nov, 2024

HIV/AIDS disaster

A TORTUROUS sense of déjà vu is attached to the latest health fiasco at Multan’s Nishtar Hospital. The largest...
Dubious pardon
21 Nov, 2024

Dubious pardon

IT is disturbing how a crime as grave as custodial death has culminated in an out-of-court ‘settlement’. The...
Islamabad protest
Updated 20 Nov, 2024

Islamabad protest

As Nov 24 draws nearer, both the PTI and the Islamabad administration must remain wary and keep within the limits of reason and the law.
PIA uncertainty
20 Nov, 2024

PIA uncertainty

THE failed attempt to privatise the national flag carrier late last month has led to a fierce debate around the...
T20 disappointment
20 Nov, 2024

T20 disappointment

AFTER experiencing the historic high of the One-day International series triumph against Australia, Pakistan came...